Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:556-558 (8 March), doi:10.1136/bmj.39484.712616.AD
J Dalrymple, general practitioner1, I Bullock, director of National Collaborating Centre for Nursing and Supportive Care2
1 Drayton & St Faiths Medical Practice, Norwich NR8 6EE, 2 Royal College of Nursing, Oxford
Correspondence to: J Dalrymple james.dalrymple3@btinternet.com
| The first 150 words of the full text of this article appear below. |
Irritable bowel syndrome (IBS) is a chronic, relapsing, and often lifelong condition of unknown aetiology,1 often associated with non-colonic symptoms. In clinical practice IBS is often diagnosed by the exclusion of more serious illnesses by unnecessary investigations and inappropriate referral. This article summarises the most recent guidance on IBS from the National Institute for Health and Clinical Excellence (NICE); the guidelines cover the diagnosis and management of the syndrome, reflecting the complete patient journey from presentation to positive diagnosis and management.2
NICE recommendations are based on systematic reviews of best available evidence. When minimal evidence is available, recommendations are based on the guideline development groups opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets.
Read all Rapid Responses